~~<i id='7724B08571'><strike id='7724B08571'><tt id='7724B08571'><pre id='7724B08571'></pre></tt></strike></i>~~

Home» Wikipedia» focus

focus

author：fashion 2025-10-06 14:33:45 Page View：9314

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates
Next article： Wildfire smoke exposes gaps in outdoor worker protections

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

Biden warns of ‘dark winter’ during final presidental debate

DemocraticpresidentialcandidateformerVicePresidentJoeBidenanswersaquestionasPresidentTrumplistensdur

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

CDC Director Mandy Cohen on transparency, trust, and health

CDCDirectorMandyCohenCliffOwen/APThenewdirectoroftheCentersforDiseaseControlandPrevention,MandyCohen